Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light
CA 2180977 C · Owner: Rywkin, Shanti · Inventors: Rywkin, Shanti; Ben-Hur, Ehud; Horowitz, Bernard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is an improved process for irradiating cell-containing compositions especially, red cell-containing compositions wherein vitamin E or a , derivative thereof is added to the cell-containing composition prior to during or after such irradiation. Addition of vitamin E or a derivative thereof is protective of cells in such compositions but not of virus. Cells , irradiated using the inventive process show a reduced leakage of K+ from cells and also a reduced loss of negative charges from the cell membrane compared to cells subjected to the similar process wherein vitamin E or a derivative thereof are not used. In addition, red blood cells sterilized by this process are better …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 3, 1995 and granted February 13, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 3, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 3, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.